Results 21 to 30 of about 552,614 (314)

In vitro properties of patient serum predict clinical outcome after high dose rate brachytherapy of hepatocellular carcinoma

open access: yesMolecular Oncology, EarlyView.
Following high dose rate brachytherapy (HDR‐BT) for hepatocellular carcinoma (HCC), patients were classified as responders and nonresponders. Post‐therapy serum induced increased BrdU incorporation and Cyclin E expression of Huh7 and HepG2 cells in nonresponders, but decreased levels in responders.
Lukas Salvermoser   +14 more
wiley   +1 more source

Combined Pulmonary Tuberculosis with Pulmonary and Pleural Cryptococcosis in a Patient Receiving Ruxolitinib Therapy

open access: yesInfection and Drug Resistance, 2021
Akarawut Kasemchaiyanun,1 Thitiporn Suwatanapongched,2 Pimpin Incharoen,3 Sirithep Plumworasawat,3 Jackrapong Bruminhent4 1Division of Pulmonary and Critical Care Medicine, Department of Medicine, Faculty of Medicine Ramathibodi Hospital, Mahidol ...
Kasemchaiyanun A   +4 more
doaj  

Carolyn Parry Decker [PDF]

open access: yes, 2015
Dr. Parry, a Pennsylvania native, graduated from Abington Friends School in 1957. She went on to attend Beaver College (now Arcadia University), where she graduated in 1961 before coming to Jefferson Medical College, becoming a member of the first class ...
Decker, Carolyn, Duinkerken, Kelsey
core   +1 more source

The organizational implications of medical imaging in the context of Malaysian hospitals [PDF]

open access: yes, 2010
This research investigated the implementation and use of medical imaging in the context of Malaysian hospitals. In this report medical imaging refers to PACS, RIS/HIS and imaging modalities which are linked through a computer network.
Mohd Nor, Rohaya, Mohd Nor, Rohaya
core   +1 more source

Feasibility of a ctDNA multigenic panel for non‐small‐cell lung cancer early detection and disease surveillance

open access: yesMolecular Oncology, EarlyView.
Plasma‐based detection of actionable mutations is a promising approach in lung cancer management. Analysis of ctDNA with a multigene NGS panel identified TP53, KRAS, and EGFR as the most frequently altered, with TP53 and KRAS in treatment‐naïve patients and TP53 and EGFR in previously treated patients.
Giovanna Maria Stanfoca Casagrande   +11 more
wiley   +1 more source

Application of Radiation Safety in Radiology Installation Hospital of Lung in South Sumatra 2013 [PDF]

open access: yes, 2013
Background : The high use of radiation for medical activities is the contribution of the second largest source of radiation we receive. Besides radiation gives benefits, it can also cause danger for radiation workers, people, and the environment.
Camelia, A. (Anita)   +2 more
core  

ACR Accreditation for Utah Valley Hospital’s Radiation Oncology Center

open access: yes, 2019
Becoming an accredited clinic through the American College of Radiology (ACR) and their Radiation Oncology Practice Accreditation (ROPA) program will provide third-party evaluation of patient care to ensure the best treatment possible for patients.
Manigold, Remy
core   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

open access: yesMolecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard   +12 more
wiley   +1 more source

Analisis Kebijakan Investasi Alat Radiologi C-Arm Rumah Sakit X [PDF]

open access: yes, 2016
AbstackBackground: Hospital X is located in the inter-provincial roads with a traffic accident incidence rate of 80%. RS adopted a policy to invest C-Arm radiological tool as powerful tools that can help in the management of surgical case. C-Arm have not
Andampury, F. S. (Fasha)   +2 more
core  

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard   +5 more
wiley   +1 more source

Home - About - Disclaimer - Privacy